SERUM STABLE BINDING PROTEINS FOR HUMAN HER2 FOR THERANOSTIC APPLICATIONS

The present disclosure relates to new serum stable non-immunoglobulin binding proteins based on ubiquitin scaffold that are highly specific for membrane-bound receptor tyrosine kinase (Her2). The disclosure provides novel specific recombinant Her2 binding proteins with high serum stability essential...

Full description

Saved in:
Bibliographic Details
Main Authors ULRICH HAUPTS, EVA BOSSE-DOENECKE, MANJA GLOSER-BRÄUNIG
Format Patent
LanguageEnglish
Published 24.04.2024
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to new serum stable non-immunoglobulin binding proteins based on ubiquitin scaffold that are highly specific for membrane-bound receptor tyrosine kinase (Her2). The disclosure provides novel specific recombinant Her2 binding proteins with high serum stability essentially combined with high temperature stability and high affinity for Her2 for uses in medical applications for diagnosis or therapy of cancer with Her2 overexpression, in particular, for radiopharmaceutical applications.
Bibliography:Application Number: ZA20220012345